Frontiers in Aging (Jun 2024)

Circulating GDF-15: a biomarker for metabolic dysregulation and aging in people living with HIV

  • Ling Wang,
  • Ling Wang,
  • Juan Zhao,
  • Juan Zhao,
  • Madison Schank,
  • Madison Schank,
  • Addison C. Hill,
  • Addison C. Hill,
  • Puja Banik,
  • Puja Banik,
  • Yi Zhang,
  • Yi Zhang,
  • Xiao Y. Wu,
  • Xiao Y. Wu,
  • Janet W. Lightner,
  • Janet W. Lightner,
  • Shunbin Ning,
  • Shunbin Ning,
  • Mohamed El Gazzar,
  • Mohamed El Gazzar,
  • Jonathan P. Moorman,
  • Jonathan P. Moorman,
  • Jonathan P. Moorman,
  • Zhi Q. Yao,
  • Zhi Q. Yao,
  • Zhi Q. Yao

DOI
https://doi.org/10.3389/fragi.2024.1414866
Journal volume & issue
Vol. 5

Abstract

Read online

Despite effective control of HIV replication by antiretroviral therapy (ART), a significant number of people living with HIV (PLWH) fail to achieve complete immune reconstitution and thus are deemed immune non-responders (INRs). Compared with immune responders (IRs) who have restored their CD4 T cell numbers and functions, CD4 T cells from these INRs exhibit prominent mitochondrial dysfunction and premature aging, which play a major role in increasing the incidence of non-AIDS, non-communicable diseases (NCDs). To date, there are no reliable biomarkers that can be used to typify and manage PLWH, especially INRs with non-AIDS NCDs. Growth differential factor-15 (GDF-15) is a transforming growth factor-β (TGF-β) family member known to regulate several biological processes involved in cell aging and stress responses. Since PLWH exhibit premature aging and metabolic dysregulation, here we measured the plasma levels of GDF-15 by ELISA and metabolic proteins by proteomic array and correlated the results with clinical parameters in ART-controlled PLWH (including INRs and IRs) and healthy subjects (HS). We found that GDF-15 levels were significantly elevated in PLWH compared to HS. GDF-15 levels were positively correlated with age and negatively associated with body mass and LDL cholesterol levels in the study subjects. Also, elevated GDF-15 levels were correlated with differential dysregulation of multiple metabolic proteins in PLWH. These results suggest that GDF-15 protein may serve as a biomarker of metabolic dysregulation and aging, and this biomarker will be useful in clinical trials targeting aging and metabolic disorders in ART-treated PLWH.

Keywords